Pharmasset Inc - FORM 10-K - EX-23.1 - CONSENT OF GRANT THORNTON LLP - November 23, 2010

Attached files

file filename
10-K - FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2010 - Pharmasset Incd10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) / RULE 15D-14(A) - Pharmasset Incdex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Pharmasset Incdex322.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) / RULE 15D-14(A) - Pharmasset Incdex311.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 - Pharmasset Incdex321.htm
EX-10.1 - COLLABORATION AGREEMENT - Pharmasset Incdex101.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated November 23, 2010, with respect to the financial statements and internal control over financial reporting included in the Annual Report of Pharmasset, Inc. on Form 10-K for the year ended September 30, 2010. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Pharmasset, Inc. on Forms S-8 (File No. 333-162359, effective October 6, 2009, and File No. 333-142630, effective May 4, 2007) and on Forms S-3 (File No. 333-164744, effective February 19, 2010 and File No. 333-169112, effective September 9, 2010).

/s/ Grant Thornton LLP

Philadelphia, Pennsylvania

November 23, 2010

Pharmasset Inc Reports